DRI Healthcare Trust (TSE:DHT.UN) Receives C$17.94 Average Target Price from Brokerages

Shares of DRI Healthcare Trust (TSE:DHT.UNGet Free Report) have earned a consensus recommendation of “Moderate Buy” from the six analysts that are covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 1 year target price among analysts that have covered the stock in the last year is C$17.94.

Several research firms have recently weighed in on DHT.UN. CIBC decreased their price target on DRI Healthcare Trust from C$19.50 to C$18.00 and set an “outperform” rating for the company in a research note on Thursday, December 12th. Raymond James decreased their target price on DRI Healthcare Trust from C$23.00 to C$22.00 in a report on Wednesday, November 13th. Finally, Scotiabank upped their price target on shares of DRI Healthcare Trust from C$21.00 to C$22.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 8th.

View Our Latest Analysis on DRI Healthcare Trust

DRI Healthcare Trust Price Performance

Shares of DRI Healthcare Trust stock opened at C$12.00 on Monday. DRI Healthcare Trust has a 12 month low of C$10.39 and a 12 month high of C$17.43. The business has a fifty day simple moving average of C$12.85 and a two-hundred day simple moving average of C$13.00.

About DRI Healthcare Trust

(Get Free Report

DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.

Further Reading

Analyst Recommendations for DRI Healthcare Trust (TSE:DHT.UN)

Receive News & Ratings for DRI Healthcare Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DRI Healthcare Trust and related companies with MarketBeat.com's FREE daily email newsletter.